Lateral Clinical Trials in Boston, Massachusetts
22 recruitingBoston, Massachusetts
Showing 1–20 of 22 trials
Recruiting
Phase 2Phase 3
HEALEY ALS Platform Trial - Master Protocol
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD1,500 enrolled78 locationsNCT04297683
Recruiting
Phase 1Phase 2
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Amyotrophic Lateral Sclerosis
Vector Y Therapeutics12 enrolled11 locationsNCT07287397
Recruiting
Phase 3
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Amyotrophic Lateral Sclerosis
Prilenia500 enrolled5 locationsNCT07322003
Recruiting
EIM Via the Myolex mScan as an ALS Biomarker
Amyotrophic Lateral Sclerosis
Beth Israel Deaconess Medical Center80 enrolled6 locationsNCT06491732
Recruiting
Phase 2
Study of COYA 302 for the Treatment of ALS
Amyotrophic Lateral Sclerosis(ALS)
Coya Therapeutics120 enrolled25 locationsNCT07161999
Recruiting
Not Applicable
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
StrokeAmyotrophic Lateral SclerosisDysarthria+3 more
Paradromics2 enrolled3 locationsNCT07357428
Recruiting
Spastic Paraplegia - Centers of Excellence Research Network
Neuromuscular DiseasesPrimary Lateral SclerosisHereditary Spastic Paraplegia+6 more
Boston Children's Hospital100 enrolled11 locationsNCT06553976
Recruiting
Phase 1Phase 2
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
Sensorineural Hearing Loss, Bilateral
Akouos, Inc.22 enrolled9 locationsNCT05821959
Recruiting
Not Applicable
Improving Visual Field Deficits With Noninvasive Brain Stimulation
StrokeQuadrantanopiaCortical Blindness+6 more
Beth Israel Deaconess Medical Center24 enrolled1 locationNCT05085210
Recruiting
Intermuscular Coherence as a Biomarker for ALS
Amyotrophic Lateral Sclerosis
University of Chicago650 enrolled4 locationsNCT05104710
Recruiting
Not Applicable
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
ALS (Amyotrophic Lateral Sclerosis)
PathMaker Neurosystems Inc.15 enrolled1 locationNCT06649955
Recruiting
PREVENT ALL ALS Study
Amyotrophic Lateral Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix600 enrolled32 locationsNCT06581861
Recruiting
ASSESS ALL ALS Study
Amyotrophic Lateral Sclerosis
St. Joseph's Hospital and Medical Center, Phoenix2,000 enrolled32 locationsNCT06578195
Recruiting
Not Applicable
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
Amyotrophic Lateral SclerosisSpinal Cord Injurieslocked-in Syndrome+3 more
Leigh R. Hochberg, MD, PhD.27 enrolled5 locationsNCT00912041
Recruiting
Not Applicable
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
AnarthriaAmyotrophic Lateral SclerosisSpinal Cord Injuries+5 more
Leigh R. Hochberg, MD, PhD.3 enrolled2 locationsNCT05724173
Recruiting
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
Movement DisordersAmyotrophic Lateral SclerosisDegenerative Disorder+1 more
Target ALS Foundation, Inc.1,000 enrolled12 locationsNCT05137665
Recruiting
Not Applicable
Feasibility Tests for Various Prism Configurations for Visual Field Loss
Visual Field Defect, PeripheralHemianopia HomonymousVisual Field Defect Homonymous Bilateral+2 more
Massachusetts Eye and Ear Infirmary20 enrolled1 locationNCT04424979
Recruiting
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Amyotrophic Lateral SclerosisCorticobasal Degeneration (CBD)Progressive Supranuclear Palsy (PSP)+11 more
Mayo Clinic2,100 enrolled27 locationsNCT04363684
Recruiting
Phase 2Phase 3
RAPA-501 Therapy for ALS
Amyotrophic Lateral Sclerosis
Rapa Therapeutics LLC41 enrolled1 locationNCT04220190
Recruiting
Phase 1
A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS
Amyotrophic Lateral Sclerosis
ProJenX72 enrolled4 locationsNCT05279755